Trial
NCT05627323
CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Chimeric Therapeutics
Collaborators
—
Condition
Glioblastoma Multiforme of Brain
Intervention
CHM-1101 CAR-T cells
Why stopped
IND application withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-29